Metoclopramide Tablet
FDA Label NDC 55154-4383

36 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Metoclopramide (NDC 55154-4383). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: tardive dyskinesia, 1 indications and usage, 2.1 important administration instructions, 2.2 dosage for gastroesophageal reflux, 2.3 dosage for acute and recurrent diabetic gastroparesis, 3 dosage forms and strengths, 4 contraindications, 5.1 tardive dyskinesia, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-4383-0

METOCLOPRAMIDE TABLETS,

USP 5 mg

10 TABLETS

5mg Bag Label (3a866de8 D779 26e4 E063 6294a90abf6b 00)

5mg Bag Label (3a866de8 D779 26e4 E063 6294a90abf6b 00)

* Please review the disclaimer below.